Abstract
The Authors review and critically discuss the most recent published evidence on treatment of mild-moderate ulcerative colitis both in the induction and maintenance of remission. Evidence on each drug is introduced by the related statement of ECCO guidelines. A brief introduction on disease classification and the need of standardizing indexes of clinical and endoscopic activity is also provided. Concluding remarks stress the heterogeneity of available studies both in the selection of patients and the outcomes evaluated and suggest the development of an international consensus in setting standards which will allow studies’ results to be compared and combined to produce high quality clinical recommendations.
Keywords: Ulcerative colitis, treatment, controlled clinical trials
Reviews on Recent Clinical Trials
Title:Randomized Controlled Clinical Trials in Mild-Moderate Ulcerative Colitis
Volume: 7 Issue: 4
Author(s): Maria Cappello, Claudia Randazzo and Ivana Bravata
Affiliation:
Keywords: Ulcerative colitis, treatment, controlled clinical trials
Abstract: The Authors review and critically discuss the most recent published evidence on treatment of mild-moderate ulcerative colitis both in the induction and maintenance of remission. Evidence on each drug is introduced by the related statement of ECCO guidelines. A brief introduction on disease classification and the need of standardizing indexes of clinical and endoscopic activity is also provided. Concluding remarks stress the heterogeneity of available studies both in the selection of patients and the outcomes evaluated and suggest the development of an international consensus in setting standards which will allow studies’ results to be compared and combined to produce high quality clinical recommendations.
Export Options
About this article
Cite this article as:
Cappello Maria, Randazzo Claudia and Bravata Ivana, Randomized Controlled Clinical Trials in Mild-Moderate Ulcerative Colitis, Reviews on Recent Clinical Trials 2012; 7 (4) . https://dx.doi.org/10.2174/1574887111207040256
DOI https://dx.doi.org/10.2174/1574887111207040256 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiac Toxicities of Antiangiogenic Therapies
Current Angiogenesis (Discontinued) Targeting Tumor Lymphangiogenesis: An Update
Current Medicinal Chemistry Drug Analogs of COX-2 Selective Inhibitors Lumiracoxib and Valdecoxib Derived from in silico Search and Optimization
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment
Current Drug Metabolism Open Source Software and Web Services for Designing Therapeutic Molecules
Current Topics in Medicinal Chemistry Calmodulin in Complex with Proteins and Small Molecule Ligands: Operating with the Element of Surprise; Implications for Structure-Based Drug Design
Current Computer-Aided Drug Design Emerging Technologies for Fertility Preservation in Female Patients
Current Women`s Health Reviews Zoning in on Tankyrases: A Brief Review on the Past, Present and Prospective Studies
Anti-Cancer Agents in Medicinal Chemistry Computational Approaches for Translational Oncology: Concepts and Patents
Recent Patents on Anti-Cancer Drug Discovery Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery Influence of Gold Nanoparticle Tagged Snake Venom Protein Toxin NKCT1 on Ehrlich Ascites Carcinoma (EAC) and EAC Induced Solid Tumor Bearing Male Albino Mice
Current Drug Delivery Recent Developments in Targeting Breast Cancer Stem Cells
Recent Patents on Regenerative Medicine Contrast Functions of αA- and αB-Crystallins in Cancer Development
Current Molecular Medicine Construction and Analysis of mRNA and lncRNA Regulatory Networks Reveal the Key Genes Associated with Prostate Cancer Related Fatigue During Localized Radiation Therapy
Current Bioinformatics Heterocycle-thioacetic Acid Motif: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activities
Current Pharmaceutical Design Circular RNAs and Glioma: Small Molecule with Big Actions
Current Molecular Medicine A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
Current Pharmaceutical Design Esophagogastric Cancer: Integration of Targeted Therapies into Systemic Chemotherapy
Current Cancer Drug Targets Targeting Histone Deacetylases in Neuroblastoma
Current Pharmaceutical Design